LSV Asset Management Sells 139,700 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

LSV Asset Management reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 23.6% in the 1st quarter, Holdings Channel reports. The fund owned 451,000 shares of the company’s stock after selling 139,700 shares during the quarter. LSV Asset Management’s holdings in Prestige Consumer Healthcare were worth $32,725,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Congress Wealth Management LLC DE increased its holdings in shares of Prestige Consumer Healthcare by 246.1% in the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock worth $6,993,000 after acquiring an additional 81,215 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock worth $37,061,000 after buying an additional 30,288 shares during the period. Congress Asset Management Co. MA boosted its position in shares of Prestige Consumer Healthcare by 596.2% during the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after buying an additional 581,685 shares during the period. Truist Financial Corp boosted its position in shares of Prestige Consumer Healthcare by 54.1% during the fourth quarter. Truist Financial Corp now owns 6,558 shares of the company’s stock worth $401,000 after buying an additional 2,302 shares during the period. Finally, Norges Bank acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth about $27,739,000. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 0.2 %

NYSE PBH traded up $0.12 during trading hours on Friday, hitting $70.33. 206,179 shares of the company traded hands, compared to its average volume of 247,724. The business’s 50-day moving average is $66.74 and its 200-day moving average is $67.15. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.31. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 16.87, a P/E/G ratio of 1.93 and a beta of 0.49.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The company had revenue of $277.00 million for the quarter, compared to analyst estimates of $287.42 million. During the same period last year, the company posted $1.07 earnings per share. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. Sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on PBH. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 price objective on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. DA Davidson raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $65.00 to $93.00 in a research report on Friday, June 21st. Finally, StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average target price of $98.25.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.